PMDA drug package insert
パブロン鼻炎カプセルＳα小児用
PMDA OTC drug · 大正製薬（株） · package insert May 1, 2026
Key facts
| Brand names | パブロン鼻炎カプセルＳα小児用 |
|---|---|
| Companies | 製造販売元／大正製薬（株） |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | カプセル |
| OTC effect category | 鼻炎用内服薬 |
| Package insert date | May 1, 2026 |
| PMDA document key | 400059_J1501000206 |
| PMDA company code | 400059 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: